222 related articles for article (PubMed ID: 29089545)
1. Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells.
Carnevale G; Carpino G; Cardinale V; Pisciotta A; Riccio M; Bertoni L; Gibellini L; De Biasi S; Nevi L; Costantini D; Overi D; Cossarizza A; de Pol A; Gaudio E; Alvaro D
Sci Rep; 2017 Oct; 7(1):14419. PubMed ID: 29089545
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
3. Reduced CaM/FLIP binding by a single point mutation in c-FLIP(L) modulates Fas-mediated apoptosis and decreases tumorigenesis.
Jing G; Yuan K; Liang Q; Sun Y; Mao X; McDonald JM; Chen Y
Lab Invest; 2012 Jan; 92(1):82-90. PubMed ID: 21912376
[TBL] [Abstract][Full Text] [Related]
4. The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.
Riccio M; Carnevale G; Cardinale V; Gibellini L; De Biasi S; Pisciotta A; Carpino G; Gentile R; Berloco PB; Brunelli R; Bastianelli C; Napoletano C; Cantafora A; Cossarizza A; Gaudio E; Alvaro D; De Pol A
J Hepatol; 2014 Nov; 61(5):1097-105. PubMed ID: 24953023
[TBL] [Abstract][Full Text] [Related]
5. Efficient recruitment of c-FLIP
Masuda A; Isobe Y; Sugimoto K; Yoshimori M; Arai A; Komatsu N
Cancer Sci; 2020 Mar; 111(3):807-816. PubMed ID: 31908105
[TBL] [Abstract][Full Text] [Related]
6. The role of MAPK-ERK pathway in 67-kDa laminin receptor-induced FasL expression in human cholangiocarcinoma cells.
Duan SG; Cheng L; Li DJ; Zhu J; Xiong Y; Li XW; Wang SG
Dig Dis Sci; 2010 Oct; 55(10):2844-52. PubMed ID: 20101459
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
[TBL] [Abstract][Full Text] [Related]
8. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism.
Chen XM; Gores GJ; Paya CV; LaRusso NF
Am J Physiol; 1999 Sep; 277(3):G599-608. PubMed ID: 10484385
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
Pan G; Ahn EY; Chen Y; Feng G; Reddy V; Jhala NC; McDonald JM
Int J Oncol; 2007 Oct; 31(4):843-50. PubMed ID: 17786316
[TBL] [Abstract][Full Text] [Related]
10. The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation.
Wang L; Azad N; Kongkaneramit L; Chen F; Lu Y; Jiang BH; Rojanasakul Y
J Immunol; 2008 Mar; 180(5):3072-80. PubMed ID: 18292530
[TBL] [Abstract][Full Text] [Related]
11. Regulators of apoptosis in cholangiocarcinoma.
Jhala NC; Vickers SM; Argani P; McDonald JM
Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
[TBL] [Abstract][Full Text] [Related]
14. c-Myc promotes tubular cell apoptosis in ischemia-reperfusion-induced renal injury by negatively regulating c-FLIP and enhancing FasL/Fas-mediated apoptosis pathway.
Xu D; Wang B; Chen PP; Wang YZ; Miao NJ; Yin F; Cheng Q; Zhou ZL; Xie HY; Zhou L; Liu J; Wang XX; Xue H; Zhang W; Lu LM
Acta Pharmacol Sin; 2019 Aug; 40(8):1058-1066. PubMed ID: 30593588
[TBL] [Abstract][Full Text] [Related]
15. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis.
Reich-Zeliger S; Gan J; Bachar-Lustig E; Reisner Y
J Immunol; 2004 Dec; 173(11):6660-6. PubMed ID: 15557157
[TBL] [Abstract][Full Text] [Related]
16. Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis.
Küenzi P; Schneider P; Dobbelaere DA
J Immunol; 2003 Aug; 171(3):1224-31. PubMed ID: 12874209
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.
von Rossum A; Krall R; Escalante NK; Choy JC
J Biol Chem; 2011 Jun; 286(24):21137-44. PubMed ID: 21518761
[TBL] [Abstract][Full Text] [Related]
18. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.
Korkolopoulou P; Saetta AA; Levidou G; Gigelou F; Lazaris A; Thymara I; Scliri M; Bousboukea K; Michalopoulos NV; Apostolikas N; Konstantinidou A; Tzivras M; Patsouris E
Histopathology; 2007 Aug; 51(2):150-6. PubMed ID: 17559541
[TBL] [Abstract][Full Text] [Related]
19. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.
Di Matteo S; Nevi L; Costantini D; Overi D; Carpino G; Safarikia S; Giulitti F; Napoletano C; Manzi E; De Rose AM; Melandro F; Bragazzi M; Berloco PB; Giuliante F; Grazi G; Giorgi A; Cardinale V; Adorini L; Gaudio E; Alvaro D
PLoS One; 2019; 14(1):e0210077. PubMed ID: 30677052
[TBL] [Abstract][Full Text] [Related]
20. The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis.
Haux J; Johnsen AC; Steinkjer B; Egeberg K; Sundan A; Espevik T
Cancer Immunol Immunother; 1999; 48(2-3):139-46. PubMed ID: 10414468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
